M. A. N. ŞENDUR Et Al. , "Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer," 2014 ASCO Annual Meeting , 2014
ŞENDUR, M. A. N. Et Al. 2014. Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer. 2014 ASCO Annual Meeting .
ŞENDUR, M. A. N., AKSOY, S., ÖZDEMİR, N., YORGUN, H., YILMAZ, F. M., YAZICI, O., ... Zungun, C.(2014). Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer . 2014 ASCO Annual Meeting
ŞENDUR, MEHMET Et Al. "Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer," 2014 ASCO Annual Meeting, 2014
ŞENDUR, MEHMET A. Et Al. "Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer." 2014 ASCO Annual Meeting , 2014
ŞENDUR, M. A. N. Et Al. (2014) . "Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer." 2014 ASCO Annual Meeting .
@conferencepaper{conferencepaper, author={MEHMET ALİ NAHİT ŞENDUR Et Al. }, title={Comparison of long term cardiac effects of 9 and 52 week trastuzumab in HER2 positive early breast cancer}, congress name={2014 ASCO Annual Meeting}, city={}, country={}, year={2014}}